A new approach to the screening for early disturbances in carbohydrate metabolism

The results of a population-based study involving 2 638 adult subjects residing in two districts of the Moscow region are considered in terms of the currently available screening models for detection of disturbances in carbohydrate metabolism; a new screening modality is proposed. The merits and demerits of different screening models were evaluated based on the comparison of validity of different diagnostic tests deduced from the estimation of sensitivity, specificity, and prognostic value of positive and negative results; the ROC-curve was constructed. It was shown that screening based on diagnostics of disturbances in carbohydrate metabolism from the fasting blood glucose level (FBGL) alone according to 2006 WHO diabetes criteria fails to reveal type 2 diabetes mellitus (DM2) in every fifth patient. Screening with partial exclusion of the oral glucose tolerance test (OGTT), i.e. confining it to subjects with impaired fasting glycemia (IFG) according to WHO criteria, allows up to 92.5% of DM2 cases to be diagnosed. However, this approach grossly underestimates the incidence of impaired glucose tolerance (IGT). The application of the 2003 ADA diagnostic criteria leads to a significant increase in the fraction of IFG subjects (up to 40%) while 18.2% of the patients with DM2 remain unidentified. Because the probability of diagnosis of DM2 (from 2-h point time of OGTT) and IGT increases in subjects with OGTT over 5.0 mmol/l, it appears desirable to use OGTT in the screening of cases with FBGL in excess of 5.0 mmol/l. This model may simplify the screening procedure (by avoiding OGTT) in 23.3% of those to be examined.

screening, disturbances in carbohydrate metabolism, impaired glucose tolerance, impaired fasting glycemia, type 2 diabetes mellitus, sensitivity, specificity, prognostic value

1. Wahl P.W., Savage P.J., Psaty B.M. et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet 1998;352:1012-1015.

2. Engelgau M.M., Narayan V., Herman W. Diabet Care 2000;23:10:1563-1580.

3. Сastell C., Tresserras R., Serra J. et al. Prevalence of diabetes in Catalonia (Spain) an oral glucose tolerance test-based population study. Diabetes Res Clin Pract 1999;43:33-40.

4. Harris M.I., Flegal K.M., Cowie C.C. et al. Prevalence of diabetes, impaired fasting glucose tolerance in U.S. adults. The third national health and nutrition examination survey. 1988-1994. Diabet Care 1998;21:518-524.

5. Ramachandran A., Snechalatha C., Kapur A. et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-1101.

6. Suvd J., Gerel B., Otgooloi H. et al. Glucose intolerance and associated factors in Mongolia: results of a national survey. Diabet Med 2002;19:502-508.

7. Collagiuri S., Collagiuri R., Na'ati S. et al. The prevalence of diabetes in the Kingdom of Tonga. Diabet Care 2002;25:1378-1383.

8. Cунцов Ю.И., Дедов И.И. Государственный регистр - основная информационная система для расчетов экономических затрат государства на сахарный диабет и прогнозирование. Сахарный диабет 2005;2:2-5.

9. Сунцов Ю.И. Эпидемиология и государственный регистр сахарного диабета. Сахарный диабет 2005;3:40-43.

10. Дедов И.И., Шестакова М.В. Инкретины: новая веха в лечении сахарного диабета 2-го типа. Практическое руководство для врачей. М 2010;7.

11. Дедов И.И., Фадеев В.В. Введение в диабетологию. М 1998;1518.

12. IDF diabetes atlas International diabetes federation. Fourth edition. Atlas 2009;22.

13. Lopatynski J., Mardarowicz G., Nicer T. et al. Prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland). Pol Arch Med Wewn 2001;106:3:781-786.

14. Szurkowska M., Szybinski Z., Nazim A. et al. Prevalence of type II diabetes mellitus in population of Krakow. Pol Arch Med Wewn 2001;106:3:771-779.

15. Lawrence J., Robinson A. Screaning for diabetes in general practice. Prev Cardiol 2003;6:2:78-84.

16. Демидова Т.Ю., Галиева О.Р. Профилактика и управление предиабетическими нарушениями углеводного обмена у больных с метаболическим синдромом. Ожирение и метаболизм 2007;4:19-24.

17. The effect of diet and exercise or Metformin on metabolic syndrome. Am Coll Phys 2005;142:8:1-42.

18. Knowler W.C., Barrett-Connor E., Fowler S.E. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:6:393-403.

19. International Federation of Clinical Chemistry and Laboratory Medicine, Scientific Division, Working Group on Selective Electrodes IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001;307:205-209.

20. World Health Organization. Definition, diagnosis, and classification of Diabetes Mellitus and its complications. WHO (Geneva) 1999.

21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabet Care 2003;26:3160-3167.

22. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой. М 2009.